316 related articles for article (PubMed ID: 25143377)
1. Tyrosine-based signal mediates LRP6 receptor endocytosis and desensitization of Wnt/β-catenin pathway signaling.
Liu CC; Kanekiyo T; Roth B; Bu G
J Biol Chem; 2014 Oct; 289(40):27562-70. PubMed ID: 25143377
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine phosphorylation of LRP6 by Src and Fer inhibits Wnt/β-catenin signalling.
Chen Q; Su Y; Wesslowski J; Hagemann AI; Ramialison M; Wittbrodt J; Scholpp S; Davidson G
EMBO Rep; 2014 Dec; 15(12):1254-67. PubMed ID: 25391905
[TBL] [Abstract][Full Text] [Related]
3. Wnt3a and Dkk1 regulate distinct internalization pathways of LRP6 to tune the activation of beta-catenin signaling.
Yamamoto H; Sakane H; Yamamoto H; Michiue T; Kikuchi A
Dev Cell; 2008 Jul; 15(1):37-48. PubMed ID: 18606139
[TBL] [Abstract][Full Text] [Related]
4. Angiopoietin-like 4 Is a Wnt Signaling Antagonist that Promotes LRP6 Turnover.
Kirsch N; Chang LS; Koch S; Glinka A; Dolde C; Colozza G; Benitez MDJ; De Robertis EM; Niehrs C
Dev Cell; 2017 Oct; 43(1):71-82.e6. PubMed ID: 29017031
[TBL] [Abstract][Full Text] [Related]
5. ADP-ribosylation factors 1 and 6 regulate Wnt/β-catenin signaling via control of LRP6 phosphorylation.
Kim W; Kim SY; Kim T; Kim M; Bae DJ; Choi HI; Kim IS; Jho E
Oncogene; 2013 Jul; 32(28):3390-6. PubMed ID: 22907437
[TBL] [Abstract][Full Text] [Related]
6. β-arrestin promotes Wnt-induced low density lipoprotein receptor-related protein 6 (Lrp6) phosphorylation via increased membrane recruitment of Amer1 protein.
Kríz V; Pospíchalová V; Masek J; Kilander MB; Slavík J; Tanneberger K; Schulte G; Machala M; Kozubík A; Behrens J; Bryja V
J Biol Chem; 2014 Jan; 289(2):1128-41. PubMed ID: 24265322
[TBL] [Abstract][Full Text] [Related]
7. Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells.
Lu W; Lin C; King TD; Chen H; Reynolds RC; Li Y
Cell Signal; 2012 Dec; 24(12):2291-6. PubMed ID: 22820499
[TBL] [Abstract][Full Text] [Related]
8. Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/β-catenin pathway.
Lu W; Lin C; Roberts MJ; Waud WR; Piazza GA; Li Y
PLoS One; 2011; 6(12):e29290. PubMed ID: 22195040
[TBL] [Abstract][Full Text] [Related]
9. β-Catenin-dependent pathway activation by both promiscuous "canonical" WNT3a-, and specific "noncanonical" WNT4- and WNT5a-FZD receptor combinations with strong differences in LRP5 and LRP6 dependency.
Ring L; Neth P; Weber C; Steffens S; Faussner A
Cell Signal; 2014 Feb; 26(2):260-7. PubMed ID: 24269653
[TBL] [Abstract][Full Text] [Related]
10. LRP6 mediates Wnt/β-catenin signaling and regulates adipogenic differentiation in human mesenchymal stem cells.
Peröbner I; Karow M; Jochum M; Neth P
Int J Biochem Cell Biol; 2012 Nov; 44(11):1970-82. PubMed ID: 22871567
[TBL] [Abstract][Full Text] [Related]
11. Rottlerin induces Wnt co-receptor LRP6 degradation and suppresses both Wnt/β-catenin and mTORC1 signaling in prostate and breast cancer cells.
Lu W; Lin C; Li Y
Cell Signal; 2014 Jun; 26(6):1303-9. PubMed ID: 24607787
[TBL] [Abstract][Full Text] [Related]
12. Bile salt-dependent lipase promotes the barrier integrity of Caco-2 cells by activating Wnt/β-catenin signaling via LRP6 receptor.
Qiu Y; Zhou J; Zhang D; Song H; Qian L
Cell Tissue Res; 2021 Mar; 383(3):1077-1092. PubMed ID: 33245415
[TBL] [Abstract][Full Text] [Related]
13. In Situ Fucosylation of the Wnt Co-receptor LRP6 Increases Its Endocytosis and Reduces Wnt/β-Catenin Signaling.
Hong S; Feng L; Yang Y; Jiang H; Hou X; Guo P; Marlow FL; Stanley P; Wu P
Cell Chem Biol; 2020 Sep; 27(9):1140-1150.e4. PubMed ID: 32649905
[TBL] [Abstract][Full Text] [Related]
14. Cripto-1 enhances the canonical Wnt/β-catenin signaling pathway by binding to LRP5 and LRP6 co-receptors.
Nagaoka T; Karasawa H; Turbyville T; Rangel MC; Castro NP; Gonzales M; Baker A; Seno M; Lockett S; Greer YE; Rubin JS; Salomon DS; Bianco C
Cell Signal; 2013 Jan; 25(1):178-89. PubMed ID: 23022962
[TBL] [Abstract][Full Text] [Related]
15. Receptor heterodimerization as a novel mechanism for the regulation of Wnt/β-catenin signaling.
Lee K; Shin Y; Cheng R; Park K; Hu Y; McBride J; He X; Takahashi Y; Ma JX
J Cell Sci; 2014 Nov; 127(Pt 22):4857-69. PubMed ID: 25271056
[TBL] [Abstract][Full Text] [Related]
16. Wnt3a-stimulated LRP6 phosphorylation is dependent upon arginine methylation of G3BP2.
Bikkavilli RK; Malbon CC
J Cell Sci; 2012 May; 125(Pt 10):2446-56. PubMed ID: 22357953
[TBL] [Abstract][Full Text] [Related]
17. LRP6 dimerization through its LDLR domain is required for robust canonical Wnt pathway activation.
Chen J; Yan H; Ren DN; Yin Y; Li Z; He Q; Wo D; Ho MS; Chen Y; Liu Z; Yang J; Liu S; Zhu W
Cell Signal; 2014 May; 26(5):1068-74. PubMed ID: 24412751
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of Wt1 activates Wnt/β-catenin signaling through modulating endocytic route of LRP6 in podocyte dysfunction in vitro.
Jing Z; Wei-jie Y; Yi-Feng ZG
Cell Signal; 2015 Sep; 27(9):1772-80. PubMed ID: 26049137
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
[TBL] [Abstract][Full Text] [Related]
20. Receptor tyrosine kinase-like orphan receptor 2 (Ror2) expression creates a poised state of Wnt signaling in renal cancer.
Rasmussen NR; Wright TM; Brooks SA; Hacker KE; Debebe Z; Sendor AB; Walker MP; Major MB; Green J; Wahl GM; Rathmell WK
J Biol Chem; 2013 Sep; 288(36):26301-26310. PubMed ID: 23893409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
